Patent · US Active

Compounds for inflammation and immune-related uses

US8524756B2 · kind B2 · utility

2Cited by

25References

25Claims

0Family size

Assignee

Synta Pharmaceuticals Corp. · US

Inventors

Shoujun Chen · Bedford, US
Jun Jiang · Shanghai, CN
Hao Li · Brookline, US
David James · Cambridge, US
Dinesh U. Chimmanamada · Arlington, US
Christopher Borella · Bedford, US
Lijun Sun · Harvard, US
Yu Xie · Natick, US
Mats Holmqvist · Handen, SE
Jerome Mahiou · Lexington, US
Zhiqiang Xia · Acton, US

Key dates

Filing date	Oct 16, 2012
Grant date	Sep 3, 2013
Priority date	—
Expiry date	Oct 16, 2032

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compounds of formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.